Recently, a quasi‐lipid–enveloped (LE) form of the traditionally nonlipid‐enveloped (NLE) hepatitis A virus (HAV) was described in human serum and cell culture‐derived HAV stocks. This discovery challenges the understanding of… Click to show full abstract
Recently, a quasi‐lipid–enveloped (LE) form of the traditionally nonlipid‐enveloped (NLE) hepatitis A virus (HAV) was described in human serum and cell culture‐derived HAV stocks. This discovery challenges the understanding of HAV reduction in virus clearance studies of plasma products, which were performed under the premise of an NLE nature of this virus. Here, the presence of LE particles in HAV stocks used for reduction studies was verified, and the hypothesis that LE and NLE particles might contribute to the differential heat sensitivity of HAV variants during heat treatment of human serum albumin was evaluated.
Journal Title: Transfusion
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!